ArticleOncotarget2018

Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy.

Giuseppe Gritt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.